Clinical Trial Update: Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing LY353381 to tamoxifen in women with locally advanced or metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• LY353381
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED